Chimerix Inc. (NASDAQ: CMRX)
$0.95
+0.0117 ( +1.25% ) 524.5K
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
Market Data
Open
$0.95
Previous close
$0.94
Volume
524.5K
Market cap
$84.92M
Day range
$0.91 - $0.98
52 week range
$0.78 - $1.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 45 | May 01, 2024 |
10-q | Quarterly Reports | 55 | May 01, 2024 |
def | Proxies and info statements | 24 | Apr 26, 2024 |
4 | Insider transactions | 1 | Mar 21, 2024 |
3 | Insider transactions | 2 | Mar 21, 2024 |
8-k | 8K-related | 15 | Mar 21, 2024 |
10-k | Annual reports | 101 | Feb 29, 2024 |
8-k | 8K-related | 46 | Feb 29, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |